Global Information
회사소개 | 문의 | 비교리스트

세계의 과민성장증후군(IBS) 치료제 시장 예측(-2028년) : 신종 코로나바이러스 감염증(COVID-19)의 영향, 종류별, 제품별, 유통 채널별 분석

Irritable Bowel Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product, and Distribution Channel

리서치사 The Insight Partners
발행일 2021년 05월 상품코드 1015796
페이지 정보 영문 180 Pages 배송안내
가격
US $ 4,550 ₩ 6,463,000 PDF (Single User License)
US $ 6,550 ₩ 9,304,000 PDF (Site License)
US $ 8,550 ₩ 12,146,000 PDF (Enterprise License)


세계의 과민성장증후군(IBS) 치료제 시장 예측(-2028년) : 신종 코로나바이러스 감염증(COVID-19)의 영향, 종류별, 제품별, 유통 채널별 분석 Irritable Bowel Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product, and Distribution Channel
발행일 : 2021년 05월 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 과민성장증후군(IBS) 치료제 시장 규모는 2020년에 21억 5,389만 달러, 2028년까지 46억 30만 달러에 달할 것으로 예측됩니다. 또한 2020-2028년간 9.95%의 CAGR로 성장할 전망입니다.

세계의 과민성장증후군(IBS) 치료제(Irritable Bowel Syndrome Treatment) 시장에 대해 분석했으며, 시장의 기본 구조와 배경(주요 성장 촉진·억제요인 등), 시장 규모 동향 전망, 종류별·제품별·유통 채널별·지역별 상세 동향, 주요 기업 개요와 전략 전개 상황, 최근의 신종 코로나바이러스 감염증(COVID-19)에 따른 영향 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 과민성장증후군(IBS) 치료제 시장 : 분석 개요

제3장 분석 방법

제4장 세계의 과민성장증후군(IBS) 치료제 시장 : 시장 상황

  • 개요
  • PEST 분석
  • 전문가의 견해

제5장 과민성장증후군(IBS) 치료제 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 과민성장증후군(IBS) 치료제 시장 : 세계 시장 분석

  • 시장 매출 예측과 분석
  • 시장 규모 예측과 분석 : 지역별
  • 주요 기업의 시장 포지셔닝

제7장 과민성장증후군(IBS) 치료제 시장 : 종류별 분석

  • 개요
  • 과민성장증후군(IBS) 치료제 시장 : 종류별 시장 점유율(2020년/2028년)
  • IBS-M(혼합형 IBS)
  • IBS-D(설사형 IBS)
  • IBS-C(변비형 IBS)

제8장 과민성장증후군(IBS) 치료제 시장 : 제품별 분석

  • 개요
  • 과민성장증후군(IBS) 치료제 시장 : 제품별 시장 점유율(2020년/2028년)
  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Linaclotide
  • 기타

제9장 과민성장증후군(IBS) 치료제 시장 : 유통 채널별 분석

  • 개요
  • 과민성장증후군(IBS) 치료제 시장 : 유통 채널별 시장 점유율(2020년/2028년)
  • 병원 약국
  • 드럭스토어·소매 약국
  • 온라인 약국

제10장 과민성장증후군(IBS) 치료제 시장 : 지역별 분석

  • 북미 : 과민성장증후군(IBS) 치료제 시장
  • 유럽 : 과민성장증후군(IBS) 치료제 시장
  • 아시아태평양 : 과민성장증후군(IBS) 치료제 시장
  • 중동 및 아프리카 : 과민성장증후군(IBS) 치료제 시장
  • 중남미 : 과민성장증후군(IBS) 치료제 시장

제11장 세계의 과민성장증후군(IBS) 치료제 시장 : 신종 코로나바이러스 감염증(COVID-19) 감염 확대의 영향

  • 북미 : COVID-19 감염 확대의 영향도 평가
  • 유럽 : COVID-19 감염 확대의 영향도 평가
  • 아시아태평양 : COVID-19 감염 확대의 영향도 평가
  • 중동 및 아프리카 : COVID-19 감염 확대의 영향도 평가
  • 중남미 : COVID-19 감염 확대의 영향도 평가

제12장 과민성장증후군(IBS) 치료제 시장 : 업계 상황

  • 개요
  • 각 기업이 전개한 성장 전략
  • 유기적 발전
  • 무기적 발전

제13장 기업 개요

  • Ironwood Pharmaceuticals, Inc.
  • Sebela Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Alfasigma S.p.A.
  • Astellas Pharma Inc.
  • AstraZeneca
  • Synthetic Biologics, Inc.
  • Bausch Health Companies Inc.
  • Lannett Company Inc.
  • AbbVie Inc.

제14장 부록

KSM 21.07.27

List Of Tables

  • Table 1. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 4. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 5. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada: Irritable Bowel Syndrome (IBS) Anti-Allergy Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Europe Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Europe Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Europe Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Germany Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Germany Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Germany Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 19. UK Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 20. UK Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 21. UK Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 22. France Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 23. France Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 24. France Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Italy: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 26. Italy: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 27. Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 28. Spain: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 29. Spain: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 30. Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 31. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 32. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 33. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 34. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 35. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 36. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 37. Japan: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 38. Japan: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 39. Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 40. China: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 41. China: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 42. China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 43. India: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 44. India: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 45. India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 46. South Korea: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 47. South Korea: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 48. South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 49. Australia: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 50. Australia: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 51. Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 52. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
  • Table 53. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 55. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 59. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 60. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 61. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 62. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 63. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 64. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 65. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 66. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 67. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 68. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
  • Table 69. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 70. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 71. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 72. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 74. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 75. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 77. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 78. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 79. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 80. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 81. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 82. Organic Developments Done by Companies
  • Table 83. Inorganic Developments Done By Companies
  • Table 84. Glossary of Terms, Irritable Bowel Syndrome (IBS) Treatment Market

List Of Figures

  • Figure 1. Irritable Bowel Syndrome Treatment Market Segmentation
  • Figure 2. Irritable Bowel Syndrome Treatment Market Segmentation, By Region
  • Figure 3. Irritable Bowel Syndrome Treatment Market Overview
  • Figure 4. Mixed IBS (IBS-M) is Expected to Show Remarkable Growth During Forecast Period
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Irritable Bowel Syndrome Treatment Market, by Geography (US$ Million)
  • Figure 7. Global Irritable Bowel Syndrome Treatment Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Irritable Bowel Syndrome Treatment Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Global Irritable Bowel Syndrome Treatment Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 15. Global Irritable Bowel Syndrome Treatment Market - By Geography Forecast and Analysis - 2020- 2028
  • Figure 16. Market Positioning of Key Players in Global Irritable Bowel Syndrome Treatment Market
  • Figure 17. Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
  • Figure 18. Mixed IBS (IBS-M) Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 19. IBS with Diarrhea (IBS-D) Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 20. IBS with Constipation (IBS-C) Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 21. Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
  • Figure 22. Rifaximin Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 23. Eluxadoline Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 24. Lubiprostone Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 25. Linaclotide Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 26. Others Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 27. Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
  • Figure 28. Hospitals Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 29. Drug Stores and Retail Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 30. Online Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
  • Figure 31. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 32. North America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 33. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
  • Figure 34. US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 36. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 37. Europe: Irritable Bowel Syndrome Treatment Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 38. Europe Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 39. Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
  • Figure 40. Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 41. UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 42. France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 43. Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 44. Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 45. Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 46. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 47. Asia Pacific: Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 48. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
  • Figure 49. Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 50. China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 51. India: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 52. South Korea: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 53. Australia: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 55. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
  • Figure 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 59. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 60. UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 61. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 62. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 63. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
  • Figure 64. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
  • Figure 65. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 66. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 67. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 72. Impact of COVID-19 Pandemic in South and Central America Country Markets
  • Figure 73. Growth Strategies Done by the Companies in the Market, (%)

The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 9.95% during 2020-2028.

The factors such as increasing prevalence of irritable bowel syndrome (IBS) diseases and rising research & development activities drive the market growth. Moreover, product innovations are expected to foster the market growth during the forecast period. However, the limited number of product availability and treatment inefficiency hinder the growth of the irritable bowel syndrome (IBS) treatment market. Additionally, in North America, medical device companies are finding difficulties in managing their operations due to the ongoing COVID-19 pandemic. Research studies published in Wolters Kluwer Health, Inc. (a US-based global leader in professional information, software solutions, and services for the health) stated that the COVID-19 pandemic is related to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with IBS and comorbid anxiety or/and depression.

The global irritable bowel syndrome (IBS) treatment market is segmented on the basis of type, product, and distribution channel. Based on type, the market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). The mixed IBS (IBS-M) segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during 2021-2028. The irritable bowel syndrome (IBS) treatment market, based on product, is segmented into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. The linaclotide segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the market is segmented into hospitals pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospitals pharmacies segment held the largest market share in 2020. However, the drug stores and retail pharmacies segment is estimated to register the highest CAGR during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the International Foundation for Gastrointestinal Disorders are among the primary and secondary sources referred to while preparing the report on the irritable bowel syndrome (IBS) treatment market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the irritable bowel syndrome (IBS) treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global irritable bowel syndrome (IBS) treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Irritable Bowel Syndrome Treatment Market - By Type
    • 1.3.2 Global Irritable Bowel Syndrome Treatment Market - By Product
    • 1.3.3 Global Irritable Bowel Syndrome Treatment Market - By Distribution Channel
    • 1.3.4 Global Irritable Bowel Syndrome Treatment Market - By Geography

2. Irritable Bowel Syndrome Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Irritable Bowel Syndrome Treatment Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Irritable Bowel Syndrome Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
    • 5.1.2 Increasing Number of FDA Approvals and Drug Developments
  • 5.2 Key Market Restraints
    • 5.2.1 Limited Number of Product Availability and Treatment Inefficiency
    • 5.2.2 Disruptive Effect of Corona Virus on the Economy
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Disposable Incomes of The Population
    • 5.3.2 Proliferation of Pharmaceutical Sector in Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Development of Medical Devices for The Treatment of Irritable Bowel Syndrome
  • 5.5 Impact Analysis

6. Irritable Bowel Syndrome Treatment Market - Global Analysis

  • 6.1 Global Irritable Bowel Syndrome Treatment Market Revenue Forecast and Analysis
  • 6.2 Global Irritable Bowel Syndrome Treatment Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Irritable Bowel Syndrome Treatment Market Analysis - By Type

  • 7.1 Overview
  • 7.2 Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
  • 7.3 Mixed IBS (IBS-M)
    • 7.3.1 Overview
    • 7.3.2 Mixed IBS (IBS-M) Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 IBS with Diarrhea (IBS-D)
      • 7.4.1.1 IBS with Diarrhea (IBS-D) Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 IBS with Constipation (IBS-C)
      • 7.5.1.1 IBS with Constipation (IBS-C) Market Revenue and Forecast to 2028 (US$ Mn)

8. Irritable Bowel Syndrome Treatment Market Analysis - By Product

  • 8.1 Overview
  • 8.2 Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
  • 8.3 Rifaximin
    • 8.3.1 Overview
    • 8.3.2 Rifaximin Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Eluxadoline
    • 8.4.1 Overview
    • 8.4.2 Eluxadoline Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.5 Lubiprostone
    • 8.5.1 Overview
    • 8.5.2 Lubiprostone Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.6 Linaclotide
    • 8.6.1 Overview
    • 8.6.2 Linaclotide Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

9. Irritable Bowel Syndrome Treatment Market Analysis - By Distribution Channel

  • 9.1 Overview
  • 9.2 Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
  • 9.3 Hospitals Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospitals Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Drug Stores and Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Drug Stores and Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10. Irritable Bowel Syndrome (IBS) Treatment Market - Geographical Analysis

  • 10.1 North America: Irritable Bowel Syndrome (IBS) Treatment Market
    • 10.1.1 Overview
    • 10.1.2 North America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 10.1.3 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
    • 10.1.4 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
    • 10.1.5 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.6 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
    • 10.1.7 US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.7.1 US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.7.2 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.1.7.3 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.1.7.4 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.8 Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.8.1 Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.8.2 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.1.8.3 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.1.8.4 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.9 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.9.1 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.9.2 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.1.9.3 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.1.9.4 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.2 Europe: Irritable Bowel Syndrome Treatment Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 10.2.3 Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
    • 10.2.4 Europe: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
    • 10.2.5 Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
    • 10.2.6 Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
    • 10.2.7 Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.7.1 Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.7.2 Germany: Irritable Bowel Syndrome Treatment Market, by Type 2019-2028 (USD Million)
      • 10.2.7.3 Germany: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
      • 10.2.7.4 Germany: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
    • 10.2.8 UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.8.1 UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.8.2 UK: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.2.8.3 UK: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
      • 10.2.8.4 UK: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
    • 10.2.9 France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.9.1 France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.9.2 France: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.2.9.3 France: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
      • 10.2.9.4 France: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
    • 10.2.10 Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.10.1 Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.10.2 Italy: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.2.10.3 Italy: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.2.10.4 Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.11 Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.11.1.1 Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.11.2 Spain: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.2.11.3 Spain: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.2.11.4 Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.12 Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.12.1.1 Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.12.2 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.2.12.3 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.2.12.4 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 10.3.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
    • 10.3.4 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
    • 10.3.5 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.6 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
    • 10.3.7 Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 10.3.7.1.1 Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.7.2 Japan: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.7.3 Japan: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.7.4 Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.8 China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
        • 10.3.8.1.1 China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.8.2 China: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.8.3 China: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.8.4 China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.9 India
        • 10.3.9.1.1 India: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.9.2 India: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.9.3 India: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.9.4 India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.10 South Korea
        • 10.3.10.1.1 South Korea: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.10.2 South Korea: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.10.3 South Korea: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.10.4 South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.11 Australia
        • 10.3.11.1.1 Australia: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.11.2 Australia: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.11.3 Australia: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.11.4 Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.12 Rest of Asia Pacific
        • 10.3.12.1.1 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.12.2 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.3.12.3 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.3.12.4 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 10.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
    • 10.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
    • 10.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS), by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.6 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
    • 10.4.7 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.7.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.7.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.4.7.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.4.7.4 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.8 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.8.1 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.8.2 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.4.8.3 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.4.8.4 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.9 UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.9.1 UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.9.2 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.4.9.3 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.4.9.4 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
      • 10.4.10.4 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
    • 10.5.3 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
    • 10.5.4 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
    • 10.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
      • 10.5.5.1 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
    • 10.5.6 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.2 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.3 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.4 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
    • 10.5.7 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.2 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.3 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.4 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
    • 10.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.8.2 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
      • 10.5.8.3 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
      • 10.5.8.4 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Treatment Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Irritable Bowel Syndrome Treatment Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Ironwood Pharmaceuticals, Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sebela Pharmaceuticals, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takeda Pharmaceutical Company Limited
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Alfasigma S.p.A.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Astellas Pharma Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AstraZeneca
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Synthetic Biologics, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 1Key Developments
  • 13.8 Bausch Health Companies Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Lannett Company Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 AbbVie Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms
Back to Top
전화 문의
F A Q